Reset filters
  • 23 July 2009

Boosted and unboosted atazanavir maintain viral suppression equally well

Read the article
  • 23 July 2009

Boosted darunavir monotherapy works well in two studies

Read the article
  • 21 July 2009

DART study shows HIV treatment without lab monitoring safe, effective in Africa

Read the article
  • 13 July 2009

Further evidence of needless treatment switches in absence of viral load testing

Read the article
  • 9 April 2009

Second-line therapy

Read the article
  • 12 March 2009

Ritonavir-boosted atazanavir as protease-only maintenance therapy: 48-week results

Read the article
  • 10 February 2009

Switching from Kaletra to raltegravir improves lipid profiles at the risk of viral rebound

Read the article
  • 2 December 2008

Rare abacavir liver side-effects reported

Read the article
  • 16 November 2008

Second-line combinations fail twice as often as first-line ones in the first year

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.